Navigation Links
Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
Date:3/26/2013

i>and Quarterly Report on Form 10-Q for the quarter ended September 30, 2012.  Anthera disclaims any intent or obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as required by applicable law.

CONTACT: Bianca Nery of Anthera Pharmaceuticals, Inc., bnery@anthera.com or 510.856.5586.ANTHERA PHARMACEUTICALS, INC.A Development Stage CompanySTATEMENT OF OPERATIONS(unaudited)(in thousands except share and per share data)Three Months Ended Dec 31,Twelve Months Ended Dec 31,2012201120122011OPERATING EXPENSE:  Research and development

$
7,089$
26,832$
49,219$
85,281  General and administrative

1,0001,5976,7157,857Total operating expense

8,08928,42955,93493,138LOSS FROM OPERATIONS:

(8,089)(28,429)(55,934)(93,138)OTHER (EXPENSE)/INCOME:Other (expense) income

(27)185(111)606Interest expense

(797)(912)(3,354)(2,803)Total other income (expense)

(824)(727)(3,465)(2,197)NET LOSS

$  (8,913)$   (29,156)$  (59,399)$   (95,335)Net loss per share--basic and diluted

$
(0.11)$
(0.71)$
(1.03)$
(2.55) Weighted-average number of shares used in per share calculation-- basic and diluted

79,120,94040,916,66657,803,49137,417,775 

 ANTHERA PHARMACEUTICALS, INC.A Development Stage CompanyBALANCE SHEET DATA(unaudited)(in thousands except share amounts)December 31,
2012December 31,
2011Cash and cash equivalents

$
9,431$
5,624Short term investments

$
5,322$
,746Total assets

$
26,445$
9,493Total current liabilities, excluding current portion of notes payable

$
9,421$
26,078Total notes payable

$
20,550$
24,331Deficit accumulated during development stage

$  (260,378)$  (200,979)Total sh
'/>"/>

SOURCE Anthera Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Anthera Pharmaceuticals Reports 2012 Third Quarter Financial Results And Provides Clinical Progress Update
2. Anthera to Report Second Quarter 2012 Financial Results
3. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2012 Financial Results
4. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
5. Keryx Biopharmaceuticals to Present at the 25th Annual ROTH Conference
6. Regeneron Pharmaceuticals’ Industrial Operations & Product Supply Site Receives International Recognition for Operational Excellence
7. Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
8. Radiopharmaceuticals Market - Global Industry Analysis, Size, Share, Trends And Forecast, 2012 - 2018: MarketResearchReports.Biz
9. Alexandria Real Estate Equities, Inc. Announces Long-Term Lease with Leading Global Commercial-Stage Oncology Company, Onyx Pharmaceuticals, Inc., for New Build-to-Suit Facility in South San Francisco, California
10. AVANIR Pharmaceuticals To participate in two conferences in March
11. Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/17/2014)... ROCKVILLE, Md. , Dec. 17, 2014 ... biopharmaceutical company dedicated to the acquisition, development and commercialization ... needs for the global market with a primary commercial ... that it has been granted a Type C meeting ... that the meeting will be held in February 2015.  ...
(Date:12/17/2014)... 17, 2014   Synageva BioPharma Corp. (NASDAQ: ... products for rare disorders, announced today its presentation at ... San Francisco, CA. ... Officer, will present on Monday, January 12, 2015, at ... be webcast live and may be accessed from the ...
(Date:12/15/2014)... & PETACH TIKVAH, Israel , Dec. ... BCLI ), a leading developer of adult stem ... subsidiary Brainstorm Cell Therapeutics Ltd. was awarded a grant ... Office of the Chief Scientist (OCS).  This is ... of grant support from the Office of the Chief ...
Breaking Biology Technology:Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
... 2010 (BRONX, NY) By constructing a microscope ... cells, researchers at Albert Einstein College of Medicine ... that occur during one of the most important "trips" ... Ribonucleic acid (RNA) molecules from the nucleus into the ...
... , This release is available in Greek , ... , An international research group led by scientists from the University ... could soon be used to perform complex calculations that cannot be ... Quantum Photonics have developed a silicon chip that could be used ...
... Sept. 16 In response to recent press coverage ... park in Minnesota, Burrill & Company would like to ... "We have been in active discussions for several ... in the project," said G. Steven Burrill, CEO, Burrill ...
Cached Biology Technology:Nature study shows how molecules escape from the nucleus 2Nature study shows how molecules escape from the nucleus 3Optical chip enables new approach to quantum computing 2Optical chip enables new approach to quantum computing 3Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run 2
(Date:12/4/2014)... Fla. , Dec. 3, 2014  Crossmatch™, ... today announced that its DigitalPersona ® Pro ... readers have been deployed throughout First Bank branch ... South Carolina and Virginia. First ... Southern Pines, North Carolina , ...
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... New York College, and one of the most prolific ... signals that are transmitted from Smartphones to third party ... Smartphones and has one of the earliest known patents ... its usage in the military, child care, elder care ...
(Date:11/18/2014)... , Nov. 18, 2014  The Secure Identity ... Association today jointly announce the formation of The ... of its Identity and Biometric Entry and ... Framework received official support from BORDERPOL, the international ... improve and provide expertise regarding border security, traveler ...
Breaking Biology News(10 mins):First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 2Identity Management, Document Authentication and Biometric Companies Form "The Airport Entry and Exit Working Group", Releasing the Framework to Help Guide the Department of Homeland Security and Congress Towards Solutions 3
... Spanish and French researchers has undertaken a pioneer analysis ... Areas (MPA) in the Mediterranean and the impact that ... a guarantee for conserving this species., Mediterranean red coral ... jewellery since ancient times. But intensive fishing, particularly in ...
... The U.S. Environmental Protection Agency (EPA) has awarded ... their work in eight key environmental areas: monitoring ... drinking water monitoring, hazardous waste monitoring, water infrastructure, ... year, the companies received "proof of concept" awards ...
... Tufts University,s School of Arts and Sciences has received ... will house a Collaborative Cluster in Genome Structure and ... bring together experts in such areas as genome structure ... to focus on "genome to organism" research to advance ...
Cached Biology News:Marine protected areas conserve Mediterranean red coral 2EPA awards small businesses to develop new environmental technologies 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 2Tufts wins NCRR grant for Collaborative Cluster in Genome Structure and Developmental Patterning 3
Improve inventory management with stainless steel red cell canisters; ensure product safety with CO2 or LN2 backup systems. A complete solution for your blood banking needs....
The mini vertical flow workbench is designed to perform PCR protocols in a particle-free environment. The built-in UV light ensures the elimination of any nucleic acid to avoid cross-contamination....
Request Info...
... Cellject Uno Electroporator is a simple, ... optimum efficiencies in bacterial and yeast ... one of two voltages and either ... mm cuvettes. On pressing the pulse ...
Biology Products: